The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $150.76

Today's change-0.55 -0.36%
Updated July 22 4:00 PM EDT. Delayed by at least 15 minutes.
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $150.76

Today's change-0.55 -0.36%
Updated July 22 4:00 PM EDT. Delayed by at least 15 minutes.

Illumina Inc down (U.S.)$0.55

Illumina Inc closed lower Friday, dropping (U.S.)$0.55 or 0.36% to (U.S.)$150.76. Over the last five days, shares have gained 1.38%, but are down 21.46% for the last year to date. Shares have underperformed the S&P 500 by 33.56% during the last year.

Key company metrics

  • Open(U.S.) $151.96
  • Previous close(U.S.) $151.31
  • High(U.S.) $151.96
  • Low(U.S.) $149.67
  • Bid / Ask(U.S.) $148.50 / (U.S.) $152.00
  • YTD % change-21.46%
  • Volume541,670
  • Average volume (10-day)881,108
  • Average volume (1-month)1,197,531
  • Average volume (3-month)1,327,302
  • 52-week range(U.S.) $127.10 to (U.S.) $223.24
  • Beta0.83
  • Trailing P/E54.21×
  • P/E 1 year forward44.71×
  • Forward PEG2.72×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.78
Updated July 22 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.11%

Based on its net profit margin of 18.11%, Illumina Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.24%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 03, 201604/03/2016Jan 03, 201601/03/2016Sep 27, 201509/27/2015Jun 28, 201506/28/2015
Revenue572592550539
Total other revenue--------
Total revenue572592550539
Gross profit397410388376
Total cost of revenue175181163163
Total operating expense450448409387
Selling / general / administrative149147137124
Research & development1241149996
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)25114
Other operating expenses, total--------
Operating income121144141152
Interest income (expense), net non-operating-9-7-13-11
Gain (loss) on sale of assets--------
Other--------
Income before tax116135129141
Income after tax87103116102
Income tax, total28321339
Net income90104118102
Total adjustments to net income--------
Net income before extra. items90104118102
Minority interest223--
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items90104118102
Inc. avail. to common incl. extra. items90104118102
Diluted net income90104118102
Dilution adjustment--------
Diluted weighted average shares148149150149
Diluted EPS excluding extraordinary itemsvalue per share0.600.700.790.69
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.620.730.850.70